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Abstract
 
Attachment of 
 
Helicobacter pylori 
 
to gastric epithelial cells induces various cellular responses, in-
cluding the tyrosine phosphorylation of an unknown 145-kD protein and interleukin 8 pro-
duction. Here we show that this 145-kD protein is the 
 
cagA
 
 product of 
 
H
 
.
 
 pylori
 
, an immuno-
dominant, cytotoxin-associated antigen. Epithelial cells infected with various 
 
H
 
.
 
 pylori
 
 clinical
isolates resulted in generation of tyrosine-phosphorylated proteins ranging from 130 to 145 kD
in size that were also induced in vitro by mixing host cell lysate with bacterial lysate. When ep-
 
ithelial cells were infected with
 
 
 
[
 
35
 
S]methionine-labeled 
 
H
 
.
 
 pylori
 
, a radioactive 145-kD protein
was detected in the immunoprecipitates with antiphosphotyrosine antibody or anti-CagA (cy-
totoxin-associated gene A) antibody. Consistently, the 145-kD protein recognized by the anti-
CagA and antiphosphotyrosine antibodies was induced in epithelial cells after infection of wild-
type 
 
H
 
.
 
 pylori 
 
but not the 
 
cagA
 
::Km mutant. Furthermore, the amino acid sequence of the
phosphorylated 145-kD protein induced by 
 
H
 
.
 
 pylori
 
 infection was identical to the 
 
H
 
.
 
 pylori
 
CagA sequence. These results reveal that the tyrosine-phosphorylated 145-kD protein is 
 
H
 
.
 
 py-
lori 
 
CagA protein, which may be delivered from attached bacteria into the host cytoplasm. The
identification of the tyrosine-phosphorylated protein will thus provide further insights into un-
derstanding the precise roles of CagA protein in 
 
H
 
.
 
 pylori
 
 pathogenesis.
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Introduction
 
Helicobacter pylori, 
 
a spiral, Gram-negative, microaerophilic
bacterium, is a human pathogen responsible for chronic ac-
tive gastritis, and infection with this organism is an impor-
tant risk factor for the development of peptic ulcer, gastric
cancer, and mucosa-associated lymphoid tissue lymphoma
(1–5). Several putative
 
 H
 
.
 
 pylori
 
 virulence factors have been
identified, including urease, the vacuolating cytotoxin
VacA, and the cytotoxin-associated gene A antigen CagA
(6, 7). Most of the clinical isolates of 
 
H
 
.
 
 pylori
 
 from patients
suffering from peptic ulcer or malignant disease express
these virulence-associated factors (8, 9). 
 
H
 
.
 
 pylori 
 
strains
may be divided into two broad families, type I and type II,
based on whether or not they possess the 
 
cag
 
 pathogenicity
island (PAI).
 
1
 
 Type I strains are those that contain the 
 
cag
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PAI, whereas type II strains lack functional 
 
cag
 
 PAI (10).
Serological studies have indicated that patients with
duodenitis, duodenal ulcers, and gastric tumors are most of-
ten infected by type I 
 
H
 
.
 
 pylori
 
 strains. In the mouse model,
type I 
 
H
 
.
 
 pylori
 
 strains can induce visible gastric damage,
whereas type II strains do not induce dramatic changes (9).
These studies thus suggest that Cag proteins, including
CagA encoded by the 
 
cag
 
 PAI, play important roles in the
pathogenicity of 
 
H
 
.
 
 pylori
 
 (8, 9, 11, 12).
 
H
 
.
 
 pylori
 
 attaches specifically and tightly to gastric epi-
thelial cells. The adherence of 
 
H
 
.
 
 pylori
 
 to the gastric epi-
thelial cells is an important determinant of pathogenesis.
Bacterial attachment causes microvilli effacement, actin
rearrangement, pedestal formation, and induction of IL-8
release (13), although the precise mechanisms of 
 
H
 
.
 
 pylori
 
adherence are still poorly understood. Previous studies
have reported that attachment of 
 
H
 
.
 
 pylori 
 
to cultured gas-
tric epithelial cells such as AGS cells can induce tyrosine
phosphorylation of a 145-kD host protein and accumu-
lation of F-actin beneath the bacterium (14, 15) and also
the subsequent evoked activation of nuclear factor (NF)-
 
k
 
B
and release of IL-8 (16–18). The ability of bacteria to in-
duce protein tyrosine phosphorylation, IL-8 production,
and the rearrangement of actin cytoskeletons is closely
correlated with the presence of the 
 
z
 
40-kb 
 
cag
 
 PAI (7, 14,
15). It has been suggested that the PAI DNA was inher-
ited by horizontal transfer from an unknown microor-
ganism, and the 31 genes of 
 
cag
 
 are thought to be en-
coded by a putative type IV secretion system (19, 20).
For example, the 
 
cag
 
 homologues of VirB4 (CagE), VirB7
(CagT), VirB9 (
 
cag
 
ORF528), VirB10 (
 
cag
 
ORF527), VirB11
(
 
cag
 
ORF525), and VirD4 (
 
cag
 
ORF524) of 
 
Agrobacterium
tumefaciens
 
 have been indicated to be assembled as a com-
plex and form the type IV transport machinery (19, 20).
Although the notion must still be verified in 
 
H
 
.
 
 pylori
 
, it
suggests the potential ability of 
 
H
 
.
 
 pylori
 
 to deliver bacterial
effector molecules through the putative type IV secretion
system into the attached host cells, thus enabling the bac-
teria to alter host cell signaling such as that required for
protein tyrosine phosphorylation, stimulation of IL-8 re-
lease, and induction of actin dynamics (13–15). Although
the signaling pathways involved in induction of the vari-
ous cellular responses remain unclear, persistent host cellu-
lar responses to bacterial infection are thought to be the
basis of chronic active gastritis, peptic ulcer disease, and
perhaps the oncogenic transformation that are the hall-
marks of symptomatic 
 
H
 
.
 
 pylori 
 
infection. In this sense,
elucidation of the bacterial effector molecules as well as
the host cellular responses including signaling pathways
must be important. Although the role of IL-8 in promo-
tion of inflammatory reaction to 
 
H
 
.
 
 pylori
 
 infection has
been well studied (16, 18, 21), the identity and function of
the tyrosine-phosphorylated 145-kD protein remains un-
known.
In this context, we have attempted to characterize the
tyrosine-phosphorylated 145-kD protein induced in gastric
epithelial cells by 
 
H
 
. 
 
pylori
 
 infection. In our study, we pro-
vide evidence that the tyrosine-phosphorylated protein is
 
not a host cellular protein but is rather the 
 
cagA
 
 gene prod-
uct of 
 
H
 
.
 
 pylori
 
.
 
Materials and Methods
 
Bacterial Strains, Cell Lines, and Media. H
 
.
 
 pylori
 
 standard strains
NCTC11637, NCTC11916, and ATCC43579, and its 
 
cagA
 
::Km
mutant and clinical isolates of 
 
H
 
.
 
 pylori
 
 from patients with gastric
ulcer (GU301, GU303, GU304, GU305, and GU306) or gastric
cancer (GC401 and GC402) from Fukui Medical University in
Japan were used. Before each experiment, 
 
H
 
.
 
 pylori
 
 strains were
passaged on 5% sheep blood agar plates (Nippon Becton Dickin-
son Co., Ltd.) by incubation in an atmosphere consisting of 5%
O
 
2
 
, 15% CO
 
2
 
,
 
 
 
and 80%
 
 
 
N
 
2
 
 for 2–4 d at 378C. Bacteria were cul-
tured in brucella broth (Difco Labs., Inc.) supplemented with 5%
FBS (GIBCO BRL) under the same conditions for 12–24 h at
378C with agitation (80–100 rpm/min). Human gastric adeno-
carcinoma epithelial MKN45 and AGS cells (ATCC CRL1739)
were from the Japanese Cancer Research Resources Bank and
the American Type Culture Collection, respectively. MKN45
and AGS cells were cultured in RPMI 1640 (Sigma Chemical
Co.) and DME (Nihonseiyaku) containing 10% FBS, respec-
tively.
Antibodies. The antiphosphotyrosine antibodies (mAb PY-20
and RC-20; conjugated with horseradish peroxidase) were pur-
chased from Transduction Labs., Inc. Normal rabbit and normal
mouse IgG was purchased from Santa Cruz Biotechnology, Inc.
Rabbit polyclonal anti-CagA antibody has been described (22).
Preparation of Cell Lysates and Immunoprecipitation. AGS and
MKN45 cells (5 3 106 per plate) cultured to 80% confluence
were washed once with 0.1 M PBS, pH 7.5, and then 4 ml of
fresh, antibiotic-free DME was added to each 100-mm dish. Cells
were infected with H. pylori at a multiplicity of infection of 20–
50. After incubation in a 5% CO2 atmosphere for the time indi-
cated in each figure, 5 3 106 infected cells were lysed in ice cold
1% Triton X-100 buffer (50 mM Tris/HCl, pH 7.4, 1% Triton
X-100, 5 mM EDTA, 1 mM Na3VO4, 10 mg/ml leupeptin, 10
mg/ml aprotinine, 100 mM p-tosyl-l-phenylalanine chloromethyl
ketone [TPCK], 100 mM p-tosyl-l-lysine chloromethyl ketone
[TLCK], and 1 mM PMSF). The cell lysates were centrifuged at
10,000 g for 10 min at 48C, and the supernatant (1% Triton X-
100–soluble fraction) was subsequently immunoprecipitated with
the antibodies indicated in each figure or control normal IgG for
2 h at 48C, after which protein A–Sepharose (Pharmacia Biotech)
was added for 30 min at 48C. The precipitates were washed three
times with lysis buffer and once with 10 mM Hepes/NaOH, pH
8.0, and then boiled with electrophoresis SDS sample buffer (2%
SDS, 10% glycerol, 5% 2-ME, 0.003% bromophenol blue, and
62.5 mM Tris/HCl, pH 6.8) for 3 min.
Immunoblot Analysis. Equal amounts of samples from whole
cell lysates or immunoprecipitates were separated by SDS-PAGE
(6.5% or 7.5% polyacrylamide) and blotted onto Immobilon P
(Millipore Corp.). The membranes were blocked with 5% skim
milk in T-PBS (PBS containing 0.05% Tween 20) and incubated
with a primary antibody in T-PBS for 1–2 h at room tempera-
ture. After washing with T-TBS (10 mM Tris/HCl, pH 7.4, 100
mM NaCl, 0.05% Tween 20), the membranes were incubated
with horseradish peroxidase–conjugated goat anti–rabbit IgG
polyclonal antibodies in T-TBS for 30 min and visualized with an
enhanced chemiluminescence (ECL) detection system as directed
by the manufacturer (Amersham Corp.). In the case of using an-
tiphosphotyrosine RC-20, after decantation of the primary anti-
body solution, the membrane was washed with T-TBS and visu-595 Asahi et al.
alized with the ECL detection systems described above. The
antiphosphotyrosine immunoblots of anti-CagA immunoprecipi-
tates were stripped by incubating the membranes in a removed
buffer (2% SDS, 62.5 mM Tris/HCl, pH 6.8, and 100 mM
2-ME) for 30 min at 508C and reprobed with the anti-CagA
polyclonal antibody.
In Vitro Phosphorylation Assay. AGS or MKN45 cells (3 3
107) were lysed in 1 ml of ice cold 1% NP-40 buffer (20 mM
Tris/HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 50 mM NaF,
10 mM ammonium molybdate, 1 mM Na3VO4, 10 mg/ml leu-
peptin, 10 mg/ml aprotinine, 100 mM TLCK, 100 mM TPCK,
and 1 mM PMSF) and homogenized in an Ultrasonic Disrupter
UD-201 (Tomy) three times for 45 s each time at 48C. Similarly,
H. pylori standard or clinical isolated strains (3 3 109) were lysed
in 1 ml of cold 1% NP-40 buffer and homogenized by the dis-
rupter. The host cell lysates were incubated together with the
bacterial lysates for 10 min at 308C in a phosphorylation reaction
buffer (50 mM Hepes, 40 mM ATP, 5 mM MnCl2, 100 mM
MgCl2, 100 mM Na3VO4). The lysates were boiled with the sam-
ple buffer and separated by SDS-PAGE, followed by immuno-
blotting with antiphosphotyrosine antibody (RC-20) as described
above.
Phosphorylation by c-Src Protein Tyrosine Kinase or Epidermal Growth
Factor Receptor Protein Tyrosine Kinase In Vitro. H. pylori (3 3 109
bacteria per milliliter) suspended in 1% NP-40 (40 ml) was added
into 5 ml of 103 phosphorylation reaction buffer (250 mM Tris/
HCl, pH 7.2, 400 mM ATP, 62.5 mM MnCl2, 312.5 mM MgCl2,
5 mM EGTA, 625 mM Na3VO4) together with 5 ml of human
c-Src protein tyrosine kinase (15 U; Upstate Biotechnology Inc.)
and incubated for 10 min at 308C. H. pylori (3 3 109 bacteria per
milliliter) suspended in 1% NP-40 (30 ml) was added to 20 ml of
2.53 phosphorylation reaction buffer (50 mM Hepes, pH 7.4,
100 mM ATP, 5 mM MnCl2, 12.5 mM MgCl, 5 mg/ml BSA,
125 mM Na3VO4) together with 10 ml of epidermal growth fac-
tor (EGF) receptor protein tyrosine kinase (1.39 U; Biomol Re-
search Labs., Inc.) and incubated for 10 min at 308C.
Labeling of H. pylori and Host Cells with [35S]Methionine. H.
pylori (109) were incubated in 100 ml of methionine- and FBS-
free RPMI medium containing 200 mCi [35S]methionine (NEN
Life Science Products, Inc.) in an atmosphere consisting of 5%
O2, 15% CO2, and 80% N2 for 5 h at 378C. Then, [35S]methio-
nine-labeled H. pylori were washed three times with PBS and re-
suspended in fresh RPMI containing 10% FBS. After the addition
of [35S]methionine-labeled H. pylori (2.5 3 108), nonlabeled host
cells (5 3 106 per plate) were incubated for 5 h at 378C and
washed three times with PBS. The 1% Triton X-100–soluble
fraction was immunoprecipitated with antiphosphotyrosine anti-
body (mAb PY-20) and separated by SDS-PAGE (6.5% poly-
acrylamide). The dried gels were scanned by an radioanalytic im-
aging system (Fuji BAS1500; Fuji Photo Film Co.). For labeling
of host epithelial cells with [35S]methionine, epithelial cells (5 3
106 per plate) were incubated in 2 ml of methionine- and FBS-
free RPMI medium containing 200 mCi [35S]methionine for 5 h
at 378C. After washing with PBS at room temperature, the la-
beled cells were resuspended in fresh RPMI containing 10% FBS
and added to nonlabeled H. pylori (2.5 3 108).
Construction of cagA::Km Mutant of H. pylori. The cagA::Km
mutant of H. pylori ATCC43579 was constructed by the follow-
ing method: A 2.0-kb green fluorescent protein gene and kana-
mycin-resistant cassette were ligated into the HincII site (2,352
nucleotides) of the cagA gene (pCRcagA-GK; reference 22), and
the resulting plasmid, designated pCRcagA-GK, was introduced
into ATCC43579 by electroporation. Kanamycin-resistant trans-
formants were screened for allelic exchange of cagA-GK with the
wild-type cagA gene by PCR. The disruption of the cagA gene
was further confirmed by Southern hybridization using a cagA-
specific DNA probe and by immunoblot with an anti-CagA
polyclonal antibody (22).
Peptide Mapping, Amino Acid Sequence, and Nucleotide Sequence.
For peptide mapping of the tyrosine-phosphorylated 145-kD
protein, the 145-kD protein sample was prepared by immuno-
precipitation with antiphosphotyrosine mAb PY-20 from lysates
of epithelial cells infected by H. pylori (NCTC11637; in vivo
sample) or from the reaction mixtures containing bacterial and
epithelial cell lysates incubated in the phosphorylation reaction
buffer in vitro (in vitro sample). The samples were separated on a
7.5% polyacrylamide gel and stained with Coomassie Brilliant
Blue R-250. The 145-kD protein bands were then subjected to
direct peptide sequencing analysis as follows: The 145-kD pro-
tein bands excised from the gel were treated with 50 mM Tris/
HCl buffer, pH 8.5, containing lysyl endopeptidase for 20 h at
358C using the in-gel digestion method described by Rosenfeld
et al. (23). The digestion solution was subjected to reverse-phase
HPLC (column: TSKgel ODS-80Ts QA, 2.0 3 250 mm;
TOSOH), and the peptide fragments were resolved. For amino
acid sequencing of internal portions of the 145-kD protein, three
major digested peptide fragments from in vitro or in vivo samples
designated for sequences 1, 2, and 3 were subjected to an amino
acid sequence analyzer (HP G1005A Protein Sequencing Sys-
tems; Hewlett-Packard Co.). For nucleotide sequencing of the
DNA segments encoding sequences 1, 2, and 3, each of the DNA
sequences were amplified by PCR from the chromosomal DNA
of H. pylori NCTC11637 using oligonucleotide primers (se-
quence 1: sense, 59-AAGGAGAACAATGACTAACGAA-39, and
antisense, 59-CTGCAAAAGATTGTTTGGCAGA-39; sequence
2: sense, 59-GGCAATGGTGGTCCTGGAGCTAGGC-39, and
antisense, 59-GGAAATCTTTAATCTCAGTTCGG-39; sequence
3: sense, 59-ATTTCAAATACACCAACGCCTCCA-39, and anti-
sense, 59-TTGCTTGCGTTACCTTGCTG-39).
PCR was performed under the following conditions: 958C for
5 min; 25 cycles of 948C for 30 s, 558C for 30 s, and 728C for 1
min; and 728C for 7 min. PCR products were purified using
concentrator columns (Centricon-100; Amicon, Inc.) according
to the manufacturer’s instructions. Direct sequencing was per-
formed on both strands using the fluorescent dideoxy terminator
method (ABI Prism Dye Terminator Cycle Sequencing Ready
Reaction Kit with AmpliTaq DNA polymerase, FS; Perkin-
Elmer Corp.). Sequences were analyzed using a DNA sequencer
(model 310; Applied Biosystems, Inc.) according to the manufac-
turer’s protocol.
Results
H. pylori Attachment to Gastric Epithelial Cells Induces Ty-
rosine Phosphorylation of a 145-kD Protein. To characterize
the tyrosine phosphorylation of a 145-kD protein induced
in epithelial cells infected with H. pylori, MKN45 or AGS
cells were infected with H. pylori NCTC11637, and 5 h af-
ter infection, the epithelial cells lysates were examined for
protein tyrosine phosphorylation by immunoblotting with
an antiphosphotyrosine antibody (RC-20). Upon attach-
ment of H. pylori to the epithelial cells, a tyrosine-phosphor-
ylated 145-kD protein was detected, whereas no phosphor-
ylated protein z145 kD in size was detected in either of596 Tyrosine Phosphorylation of Intracellular CagA of Helicobacter pylori
the cell lines without H. pylori infection (Fig. 1 A). To fur-
ther characterize the appearance of the phosphorylated
145-kD protein in the epithelial cells, the MKN45 cells
were sampled 15 min–24 h after infection and examined
for protein phosphorylation by immunoblotting with an-
tiphosphotyrosine antibody RC-20. As shown in Fig. 1 B,
the tyrosine phosphorylation of a 145-kD protein could be
seen at 15 min, increased to a maximum level at 5–10 h,
and declined to a low level 24 h after infection.
To confirm that the 145-kD protein was tyrosine phos-
phorylated, MKN 45 cells were treated with various con-
centrations of genistein, a tyrosine kinase inhibitor, and the
cells were infected by H. pylori for 5 h. As shown in Fig. 1
C, phosphorylation of the 145-kD protein was abrogated at
100  mg/ml (370 mM). In contrast, treatment by various
concentrations of orthovanadate, a tyrosine phosphatase in-
hibitor, increased the level of tyrosine phosphorylation of
the 145-kD protein (Fig. 1 D), implying that protein ty-
rosine kinase and protein tyrosine phosphatase activities are
involved in the phosphorylation of the 145-kD protein.
Infection of Gastric Epithelial Cells by H. pylori Clinical Isolates
Induces Diverse Tyrosine-Phosphorylated Proteins. To further
investigate the tyrosine-phosphorylated protein, H. pylori
clinical isolates from Japanese patients with gastric ulcer or
gastric cancer were examined for their ability to induce ty-
rosine phosphorylation in MKN45 or AGS cells. All of the
clinical isolates elicited tyrosine phosphorylation of 130–
135-kD proteins in both epithelial cells (Fig. 2), although
the level of tyrosine phosphorylation was lower than that
displayed by NCTC11637 or NCTC11916, indicating that
the size variation in the tyrosine-phosphorylated proteins
was dependent on the infecting H. pylori strains but not on
the epithelial cell lines.
In Vitro Phosphorylation Assay of Tyrosine-Phosphorylated
Proteins.  To determine whether the 145-kD phosphory-
lated protein evoked in the epithelial cells infected with H.
Figure 1. Immunoblot analysis of gastric epithelial cells
infected with H. pylori by antiphosphotyrosine antibody
RC-20. (A) Tyrosine phosphorylation of a 145-kD pro-
tein in MKN45 or AGS cells induced by H. pylori
NCTC11637 infection. Lanes 1 and 2, lysates of unin-
fected MKN45 or MKN45 infected with H. pylori for 5 h;
lanes 3 and 4, lysates of uninfected AGS or AGS infected
with H. pylori for 5 h. Arrowhead indicates the 145-kD
protein. (B) Time course for the expression of protein ty-
rosine phosphorylation in MKN45 cells infected with H.
pylori NCTC11637. Uninfected (lane 1) or infected (lanes
2–9) MKN45 cells were examined at the indicated times
(h) after bacterial infection. Effect of genistein (C) or vana-
date (D) on the 145-kD protein tyrosine phosphorylation
in MKN45 cells infected with H. pylori NCTC11637.
Cells were treated with various concentrations of genistein
or vanadate for 30 min at 378C before the infection. The
epithelial cells infected with H. pylori for 5 h were sampled
at the indicated concentration, and the protein tyrosine
phosphorylation in the cell lysates was examined by the
same methods as in A.
Figure 2. Diversity of tyrosine-phosphorylated large
proteins induced in epithelial cells infected with various H.
pylori strains. Protein tyrosine phosphorylation in MKN45
(A) and AGS cells (B) infected with various clinical isolates
of H. pylori for 5 h. Lane 1, uninfected control; lanes 2–7
represent protein tyrosine phosphorylation induced in epi-
thelial cells infected with NCTC11916, NCTC11637,
GU301, GU303, GC401, and GC402, respectively. Ar-
rowhead indicates the tyrosine-phosphorylated 145-kD
protein; arrow indicates the phosphorylated large proteins
in epithelial cells infected with various clinical isolates.597 Asahi et al.
pylori is a host cellular protein (13), reconstitution experi-
ments were carried out using H. pylori and epithelial cell ly-
sates in vitro. MKN45 or AGS cell lysates were or were not
combined with H. pylori lysates (from NCTC11637), incu-
bated in a phosphorylation reaction buffer containing ATP
and cations for 10 min at 378C (see Materials and Meth-
ods), analyzed by SDS-PAGE, and immunoblotted with
antiphosphotyrosine RC-20. As shown in Fig. 3 A, a 145-kD
protein was only tyrosine phosphorylated in a combi-
nation of H. pylori and epithelial cell lysates. Similarly,
when bacterial lysates from each of seven H. pylori clinical
isolates combined with MKN45 cell lysates were incubated
in the phosphorylation reaction buffer, diverse phosphory-
lated proteins z130–135 kD in size were detected (Fig. 3
B). Importantly, the size variations with GU301, GU303,
GC401, or GC402 were comparable to those seen in the
epithelial cells infected with the corresponding H. pylori
strains (Fig. 2). Under the same conditions, neither H. py-
lori lysate alone nor the epithelial cell lysate alone in the
phosphorylation reaction buffer induced protein tyrosine
phosphorylation (data not shown), strongly suggesting that
the size variation of the phosphorylated protein was depen-
dent on the bacterial strain.
To verify that the 145-kD proteins phosphorylated in
vitro and in vivo were identical, the 145-kD protein was
collected by immunoprecipitation with antiphosphoty-
rosine mAb PY-20 from in vitro or in vivo samples and di-
gested with lysyl endopeptidase using an in-gel digestion
method (see Materials and Methods). The HPLC profiles
of each digested segment of the 145-kD proteins were sim-
ilar (data not shown). To further ascertain whether the ty-
rosine-phosphorylated protein was of H. pylori origin,
NCTC11637 bacterial lysate was phosphorylated in phos-
phorylation reaction buffer in vitro using nonreceptor pro-
tein tyrosine kinase, c-Src kinase, or receptor protein ty-
rosine kinase EGF receptor kinase. Indeed, a 145-kD
protein was tyrosine phosphorylated, as determined by im-
munoblotting with antiphosphotyrosine RC-20 (data not
shown), raising the possibility that the 145-kD tyrosine-
phosphorylated protein induced in epithelial cells infected
with H. pylori is from the infecting bacteria.
Demonstration of the 145-kD Protein from H. pylori. To
directly demonstrate that the tyrosine-phosphorylated
145-kD protein was of H. pylori origin, H. pylori strain
NCTC11637 and AGS cells were labeled with [35S]me-
thionine separately, and then the nonlabeled epithelial cells
were infected with the [35S]methionine-labeled bacteria for
5 h (the [35S]methionine-labeled epithelial cells were in-
fected with nonlabeled bacteria for 5 h). The infected AGS
cells were lysed with 1% Triton X-100, and the soluble
fraction was immunoprecipitated with antiphosphotyrosine
mAb PY-20. Analysis of the precipitates revealed a 145-kD
protein labeled by [35S]methionine (Fig. 4, lane 2). Al-
though the radioactivity of the tyrosine-phosphorylated
protein was low, the labeled 145-kD protein was repro-
ducibly detected in three independent experiments. Under
the same conditions, the 145-kD protein was not detected
Figure 3. In vitro tyrosine phosphorylation of the 145-kD
protein. (A) Tyrosine phosphorylation of a 145-kD protein
induced by a combination of H. pylori NCTC11637 and
MKN45 (or AGS) cell lysates. Epithelial cell lysates with or
without bacterial lysates were added to a phosphorylation re-
action buffer and incubated for 10 min at 308C. The 145-kD
protein was detected by immunoblotting with antiphos-
photyrosine antibody RC-20. (B) Tyrosine phosphorylation
of a large protein induced by the combination of various H.
pylori strains and MKN45 cell lysates. Lanes 1–9: control
(without H. pylori lysate), NCTC11637, GU301, GU303,
GU304, GU305, GU306, GC401, and GC402, respec-
tively. Arrowhead and arrow indicate the tyrosine-phos-
phorylated 145-kD and other proteins, respectively.
Figure 4. Demonstration of the tyrosine-phosphorylated 145-kD pro-
tein derived from H. pylori. AGS cells were infected with [35S]methio-
nine-labeled or nonlabeled H. pylori for 5 h at 378C, and the cell lysates
prepared with 1% Triton X-100 were immunoprecipitated by an an-
tiphosphotyrosine mAb PY-20 or an anti-CagA polyclonal antibody. The
precipitated proteins were separated by SDS-PAGE and analyzed using a
radioanalytic imaging system. Arrowhead indicates the 145-kD protein.
Lanes 1–3, AGS infected with [35S]methionine-labeled H. pylori; lanes 4
and 5, [35S]methionine-labeled H. pylori alone; lanes 6–8, [35S]methio-
nine-labeled AGS infected with nonlabeled H. pylori; lanes 1 and 6, the 1%
Triton X-100–soluble fraction precipitated by control normal IgG; lanes
2, 4, and 7, the 1% Triton X-100–soluble fraction precipitated by an-
tiphosphotyrosine mAb PY-20; and lanes 3, 5, and 8, the 1% Triton
X-100–soluble fraction precipitated by anti-CagA polyclonal antibody.
Note that the [35S]methionine-labeled band being lower than that of
145-kD protein in lanes 3 and 5 may be bacterial protein(s) cross-reacted
with the polyclonal anti-CagA antibody.598 Tyrosine Phosphorylation of Intracellular CagA of Helicobacter pylori
in antiphosphotyrosine mAb PY-20 immunoprecipitates
from labeled bacteria alone (Fig. 4, lane 4) or from labeled
AGS cells infected with nonlabeled H. pylori (lane 7). As the
CagA protein of H. pylori ranges in size from 120 to 140 kD
in different strains (11, 22) and our data suggested that the
145-kD protein was derived from H. pylori, we reasoned
that the tyrosine-phosphorylated protein was CagA. The ly-
sates of epithelial cells infected with the [35S]methionine-
labeled H. pylori were immunoprecipitated by an anti-CagA
polyclonal antibody. As shown in Fig. 4 (lane 3), a protein
corresponding to 145 kD that was labeled by [35S]methio-
nine was immunoprecipitated with anti-CagA antibody.
Amino Acid Sequence of the 145-kD Protein. The amino
acid sequence of three internal segments of the 145-kD
protein prepared from in vitro– or in vivo–phosphorylated
sample was determined. The 145-kD phosphorylated pro-
tein was digested with lysyl endopeptidase as described
above, and the resulting three internal segments, named
segment 1, 2, and 3, were subjected to amino acid se-
quence analysis by Edman chemistry (see Materials and
Methods). The amino acid sequences in segment 1, 2, and
3 yielded the sequences DNLIDIGSSIK, NQQGDN-
VATLINVHMK, and IFALINK, respectively, which were
identical to the deduced sequences of the three internal
cagA sequences of H. pylori NCTC11637 that were ampli-
fied by PCR using three sets of oligonucleotide primers, as
Figure 5. Amino acid sequences of the tyrosine-phosphorylated 145-kD
protein. Amino acid sequences of the three internal segments of the ty-
rosine-phosphorylated 145-kD protein (145-kD seg-1, -2, and -3) from
in vitro sample (the reactant of NCTC11637 and MKN45 cell lysates in-
cubated in the phosphorylation reaction buffer in vitro), the amino acid
sequences deduced from nucleotide sequences of the DNA segments en-
coding sequences 1, 2, and 3 from NCTC11637 (NCTC 11637 seg-1,
-2, and -3), or the amino acid sequences deduced from the nucleotide se-
quences of the corresponding cagA sequence from CCUG17874 (CCUG
17874 seg-1, -2, and -3; reference 11).
Figure 6. Tyrosine phosphorylation of CagA protein in-
duced in H. pylori–infected epithelial cells. (A) Detection of
the tyrosine phosphorylation of CagA protein in AGS cells
induced by H. pylori infection. AGS cells infected with H.
pylori NCTC11637 at indicated times after infection were
lysed in a 1% Triton X-100 lysis buffer, and the soluble
fraction was immunoprecipitated with an anti-CagA poly-
clonal antibody. The precipitates were separated by SDS-
PAGE and then immunoblotted with antiphosphotyrosine
antibody RC-20 or anti-CagA polyclonal antibody. (B)
Absence of tyrosine-phosphorylated CagA protein in the
culture supernatants. The culture supernatants used for the
AGS cells infected with H. pylori NCTC11637 at the indi-
cated times were subjected to the same immunoblot analy-
sis as in A. The rightmost lane represents the tyrosine phos-
phorylation of CagA protein in AGS cells induced by H.
pylori 10 h after infection. (C) Tyrosine phosphorylation of
CagA protein in AGS cells induced by infection with H.
pylori strains NCTC11637, GU303, and GC401. The left-
most lane shows noninfected control, and the second lane
on the left shows NCTC11637 control. Top panel: ty-
rosine-phosphorylated CagA proteins detected in AGS
cells infected with H. pylori; bottom panel: the same blot
reprobed with the anti-CagA polyclonal antibody. (D) Ty-
rosine phosphorylation of CagA protein in AGS cells in-
duced by infection with ATCC43579 and the cagA::Km
mutant. Arrowhead indicates the 145-kD protein.599 Asahi et al.
described in Materials and Methods (Fig. 5). These se-
quences were further confirmed to be present in the CagA
sequence deduced from the whole cagA gene sequence of
NCTC11637 (available from EMBL/GenBank/DDBJ un-
der accession nos. NCTC11637, AF202973 and GC401,
AF202972). The amino acids of segments 1, 2, and 3 were
almost identical to the respective internal amino acid se-
quences of the CagA protein deduced from the nucleo-
tide sequences of the cagA gene of H. pylori CCUG17874
(11); sequence 1 (segment 1), sequence 2 (segment 2),
and sequence 3 (segment 3) of the CagA protein from
NCTC11637 corresponded to the internal CagA se-
quences of Asp97–Lys107, Asn339–Lys 354, and Ile655–Lys661,
respectively. Based on the results, we concluded that the
145-kD tyrosine-phosphorylated protein induced in the
epithelial cells infected with H. pylori is the CagA protein.
Intracellular CagA Protein Can Only Be Tyrosine Phosphory-
lated. To confirm the above results, the 145-kD tyrosine-
phosphorylated protein induced in AGS cells infected with
H. pylori NCTC11637 was reinvestigated by immunopre-
cipitation with anti-CagA antibody. As shown in Fig. 6 A,
the 145-kD protein precipitated with anti-CagA antibody
was detected by immunoblotting with antiphosphotyrosine
RC-20. As the CagA protein of H. pylori is secreted (24–
28), we examined whether the 145-kD protein was also se-
creted into the culture supernatant during infection. Im-
munoblot analysis with the anti-CagA antibody revealed
that the 145-kD protein was present in the culture me-
dium, the levels of which increased by 5–10 h after infec-
tion (Fig. 6 B). Importantly, protein tyrosine phosphoryla-
tion could not be detected in the culture supernatant at all
(Fig. 6 B), indicating that the intracellular CagA protein
can only undergo tyrosine phosphorylation.
We reexamined the tyrosine-phosphorylated proteins in-
duced in epithelial cells infected with H. pylori GU303 or
GC401 by immunoblotting with the anti-CagA antibody.
The 130-kD phosphorylated proteins were also detected by
the anti-CagA antibody (Fig. 6 C). H. pylori ATCC43579
and its isogenic cagA::Km mutant were similarly tested.
Whereas the wild-type H. pylori gave rise to the 145-kD
tyrosine-phosphorylated protein, the isogenic cagA::Km
mutant failed to generate the phosphorylated protein in the
infected epithelial cells (Fig. 6 D).
Discussion
In this study, we investigated the tyrosine-phosphory-
lated 145-kD protein induced in gastric epithelial cells in-
fected with H. pylori and identified the phosphorylated pro-
tein as the cagA gene product of H. pylori. Our conclusion
was based on the following results: (a) attachment of differ-
ent clinical isolates, including several standard H. pylori
strains, to epithelial cells evoked diverse sizes of tyrosine-
phosphorylated proteins ranging from 130 to 145 kD; (b)
when bacterial lysates from the clinical isolates were com-
bined with host cell lysates in vitro, diverse sizes of ty-
rosine-phosphorylated proteins were also evoked; (c) when
epithelial cells were infected with [35S]methionine-labeled
H. pylori NCTC11637, a radiolabeled 145-kD protein was
immunoprecipitated by antiphosphotyrosine mAb PY-20
and anti-CagA polyclonal antibody; (d) infection of epithe-
lial cells by a cagA::Km mutant of H. pylori failed to induce
the tyrosine phosphorylation of the 145-kD protein; and
(e) the amino acid sequence of the tyrosine-phosphorylated
145-kD protein was identical to the CagA sequence of H.
pylori.
Adherence of H. pylori to gastric epithelial cells can in-
duce host cellular responses, including the reorganization of
actin cytoskeletons (29), the tyrosine phosphorylation of a
145-kD protein (13), and release of IL-8 (15, 18, 21). The
145-kD phosphorylated protein induced in gastric epithe-
lial cells infected with H. pylori strain 87A300 was originally
reported by Segal and colleagues, who proposed that the
145-kD protein was a host cellular component (13, 14). In
a subsequent study, they examined type I H. pylori strains
together with various cag insertion mutants (cagE, cagF,
cagG, cagH, cagI, cagL, cagN, and cagM) for their ability to
induce tyrosine phosphorylation of the 145-kD protein or
IL-8 production and showed that whereas type I strains
were able to induce protein phosphorylation and IL-8 pro-
duction, all of the cag insertion mutants except for cagN
failed to induce the protein phosphorylation and IL-8, in-
dicating that for all of the cag PAI mutants, there was a cor-
relation between the ability to phosphorylate the 145-kD
protein and induction of IL-8 (15). Based on the effects of
various kinase inhibitors on phosphorylation of the 145-kD
protein and IL-8 induction as well as on the different in-
hibitory effect, Segal and colleagues proposed that two dis-
tinct signal pathways participate independently in stimula-
tion of IL-8 release and protein tyrosine phosphorylation.
Censini et al. (7) reported that KATO-III cells infected
with the cagA or cagN mutant were still able to stimulate
IL-8 release, whereas the other cag mutants (cagE, cagG,
cagH, cagI, cagL, and cagM) failed to induce IL-8 production
and NF-kB activation (15, 30). Therefore, these studies
have suggested that some of the cag genes in the cag PAI,
including the cagA gene, could be involved in the induc-
tion of phosphorylation of the 145-kD protein (7).
In this study, we confirmed that infection of gastric epi-
thelial cells by H. pylori strains such as NCTC11637,
NCTC11916, and ATCC43579 induced tyrosine phos-
phorylation of a 145-kD protein. Interestingly, when AGS
cells were infected with various H. pylori clinical isolates,
tyrosine-phosphorylated proteins ranging from 130 to 135
kD in size were evoked that were also reproducibly in-
duced in the infected MKN45 cells, raising the possibility
that the tyrosine-phosphorylated protein was not a host
cellular protein but rather derived from H. pylori. This no-
tion agreed with the results of in vitro protein phosphoryla-
tion assays using bacterial lysates and AGS cell lysates,
where the sizes of the phosphorylated proteins were com-
parable to those induced in epithelial cells infected with H.
pylori clinical isolates (Fig. 3). As the CagA protein dis-
played considerable size variation ranging from 120 to 140
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the intragenic repeat sequences in the 39 portion of the
cagA gene (11), we reasoned that the tyrosine-phosphory-
lated 145-kD protein, including the diverse phosphorylated
proteins induced in epithelial cells infected with NCTC11637
or various clinical isolates, H. pylori strains would be the
cagA product. Examination of the tyrosine-phosphorylated
145-kD protein using anti-CagA polyclonal antibody and
the direct amino acid sequencing supported our premise.
Interestingly, the levels of phosphorylation of the 130–135-
kD protein (identified as CagA) also varied among H. pylori
clinical isolates, with somewhat lower levels of phosphory-
lation than those induced by H. pylori NCTC11637 or
NCTC11916. The CagA sequences deduced from the nucle-
otide sequencing of the cagA gene in H. pylori CCUG1784
(128-kD CagA) and ACTT43526 (138-kD CagA) had two
and five copies of repeat Glu-Pro-Ile-Tyr-Ala (EPIYA) se-
quences at the 39 region, respectively (11, 22). Similarly, the
CagA sequences deduced from the nucleotide sequencing of
the cagA gene in NCTC11637 and GC401 revealed that
CagA of NCTC11637 (139-kD CagA) and GC401 (131-kD
CagA) contained five and three copies of EPIYA sequences
at the 39 region, respectively. Interestingly, one of the pu-
tative tyrosine phosphorylation sites in the EPIYA se-
quence, which is part of the Pro(Leu)-Glu-Glu-Pro-Ile-Tyr-
Ala (PEEPIYA or LEEPIYA) sequence, is similar to the
PEEHIYD sequence in the Tir protein of enteropatho-
genic  Escherichia coli (EPEC; reference 31). Notably, the ty-
rosine phosphorylation at the PEEHIYD sequence of the
EPEC Tir protein is essential for EPEC induction of the
actin nucleation activity beneath the bacterium and tight
bacterial adherence to epithelial cells (32). Although the
preferential tyrosine phosphorylation sites in the CagA
protein remain to be determined, it is likely that the dif-
ferent levels of phosphorylation of the CagA proteins in
epithelial cells induced by H. pylori clinical isolates could
partly depend on the numbers of repeated EPIYA se-
quences present in each CagA protein.
As the CagA protein can be secreted onto the bacterial
surface and also released into the culture supernatant even
in the absence of a typical leader peptide sequence (11, 24–
28), CagA secretion is thought to be exported by a sec-
independent secretion system (11, 19). In this study, we
confirmed that the 145-kD protein (and the 130–135-kD
protein) was also secreted into the culture supernatant from
various  H. pylori strains when attached to the epithelial
cells, and we identified the 145-kD protein (and the 130–
135-kD proteins) as CagA. Whereas the extracellular 145-kD
protein was not tyrosine phosphorylated at all, the intracel-
lular protein was tyrosine phosphorylated. Although the
precise mechanisms of CagA secretion from H. pylori into
the bacterial environment or host cells remains unclear, it is
tempting to speculate that H. pylori could directly deliver
the CagA protein into the host cell cytoplasm through at-
tachment to the cells, and the internalized CagA protein
could then undergo tyrosine phosphorylation by host cel-
lular tyrosine kinases. Importantly, some of the cag-encoded
proteins such as CagE, CagT, cagORF524, cagORF525,
cagORF527, cagORF528, and cagORF996 have sequence
similarities to well known proteins composing the type IV
export machineries of E. coli, Bordetella pertussis, A. tumefa-
ciens, Legionella pneumophila, Rickettsia prowazekii, and Bru-
cella suis (19, 20, 33–35). The type IV export systems
specialize in transfer of a variety of multimolecular com-
plexes across the bacterial membrane to the extracellular
space or into target host cells (19, 20). Furthermore, Segal
et al. showed that mutations in some of the cag genes such
as cagE, cagF, cagG, cagH, cagI, cagL, and cagM failed to in-
duce tyrosine phosphorylation of the 145-kD protein (15). It
is thus intriguing to speculate that the delivery of CagA
from H. pylori into the culture supernatant and the at-
tached epithelial cells could be via the putative type IV
export system.
Although the precise role of tyrosine phosphorylation of
intracellular CagA protein in the pathogenesis of H. pylori
remains to be elucidated, the behavior of CagA protein ob-
served in this study is reminiscent of the EPEC Tir protein;
the Tir protein can be directly delivered from EPEC into
attached epithelial cells though the type III secretion ma-
chinery, and the translocated protein undergoes tyrosine
phosphorylation in the host cell cytoplasm (31). In addi-
tion, both H. pylori and EPEC can attach tightly to the epi-
thelial cells, an attachment through which pathogens can
induce a local rearrangement of actin cytoskeletons, includ-
ing pedestal formation beneath the bacterium and release of
IL-8 (13, 15, 36, 37). However, CagA and Tir have no
amino acid sequence similarity. Indeed, Tir possesses two
transmembrane domains, whereas CagA has no such do-
mains, and CagA is a very hydrophilic protein (11, 31). Al-
though the tyrosine-phosphorylated Tir protein has been
implicated in induction of actin condensation beneath the
bacterium and serves as the receptor for binding to the in-
timin protein, the tyrosine-phosphorylated CagA protein
seems to have no such specific role (15, 31, 38). Instead,
CagA has been implicated in determination of the intensity
of inflammation in the gastric epithelium, a key event in
the development of gastric diseases associated with H. pylori
infection (9, 12). Thus, based on our results, the phosphor-
ylated CagA protein may also play a crucial role in promot-
ing the inflammatory responses of gastric mucosa to H.
pylori infection. The identification of the 145-kD tyrosine-
phosphorylated protein as the cagA gene product of H. py-
lori should provide further insight into the precise role of
the CagA protein in the pathogenesis of H. pylori as well as
in the development of duodenitis, duodenal ulcers, and
gastric cancer.
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